Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Human embryonic stem-cell-derived retinal pigment epithelial cells

EU orphan designation number: EU/3/11/874   
Active ingredient: Human embryonic stem-cell-derived retinal pigment epithelial cells
Indication: Treatment of Stargardt’s disease
Sponsor: Astellas Pharma Europe B.V.
Sylviusweg 62, NL-2333 BE Leiden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/06/2011 Orphan designation EMA/OD/173/10 (2011)4548 of 21/06/2011
21/12/2016 Transfer of orphan designation EMA/OD/173/10/T/01 (2016)8911 of 19/12/2016